Skip to main content
An official website of the United States government
Español
Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

Miraluma test

(meer-uh-LOO-muh ...)
A type of breast imaging test that is used to detect cancer cells in the breasts of some women who have had abnormal mammograms, or who have dense breast tissue. It is not used for screening or in place of a mammogram. In this test, a woman receives an injection of a small amount of a radioactive substance called technetium 99, which is taken up by cancer cells, and a gamma camera is used to take pictures of the breasts. Also called scintimammography and sestamibi breast imaging.
Search NCI's Dictionary of Cancer Terms